dr. pal on the sequencing of immunotherapy for urothelial carcinoma
Published 6 years ago • 87 plays • Length 1:03Download video MP4
Download video MP3
Similar videos
-
1:12
dr. pal on rcs in metastatic urothelial carcinoma
-
1:01
dr. pal on sequencing challenges for the treatment of patients with rcc
-
0:48
dr. pal on preoperative immunotherapy in patients with rcc
-
0:43
dr. pal on sequencing nivolumab in rcc
-
0:51
dr. pal on the safety profile of cabozantinib/atezolizumab in advanced rcc
-
2:03
dr. sonpavde on immunotherapy after progression in advanced bladder cancer
-
21:22
cancer immunotherapy | doctor live 22 oct 2018
-
34:39
bladder cancer and immunotherapy with dr. arjun balar
-
58:00
webinar: advanced bladder cancer
-
0:47
dr. balar on combinations with pembrolizumab for urothelial cancer
-
0:57
dr. black on sequencing of immunotherapy in bladder cancer
-
1:00
dr. sklar on immunotherapy potential in bladder cancer
-
2:00
dr. pal on adjuvant therapy of renal cell carcinoma
-
0:51
dr. balar on the approval of pembrolizumab for bladder cancer
-
1:06
dr. wright on the underutilization of bladder preservation in localized bladder cancer
-
1:02
dr. pal on the mutational burden in bladder cancer
-
0:46
dr. sonpavde on the need for phase 3 data with pembrolizumab or atezolizumab in bladder cancer
-
1:00
dr. plimack on the growth of immunotherapy in bladder cancer
-
0:43
dr. wright discusses immunotherapy in bladder cancer
-
1:05
dr. petrylak on combinations with pembrolizumab in urothelial carcinoma
-
1:21
dr. o’donnell on pd-l1 testing in bladder cancer
-
2:26
pd-l1 immunotherapy in bladder cancer